PTC THERAPEUTICS INC shareholders Q2 2023

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

PTC THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TWO SIGMA ADVISERS, LP 286,442$11,649,5960.03%
Nadler Financial Group, Inc. 4,939$200,8690.03%
Headlands Technologies LLC 2,096$85,2440.03%
ExodusPoint Capital Management, LP 65,082$2,6470.02%
WINTON GROUP Ltd 5,668$230,5180.02%
Diversified Trust Co 12,990$528,3030.02%
Caption Management, LLC 24,718$1,005,2810.02%
Graham Capital Management, L.P. 15,103$614,2390.02%
Byrne Asset Management LLC 675$270.02%
VICTORY CAPITAL MANAGEMENT INC 398,707$16,215,4140.02%
MOORE CAPITAL MANAGEMENT, LP 25,000$1,016,7500.02%
MARTINGALE ASSET MANAGEMENT L P 19,614$797,7030.02%
Russell Investments Group, Ltd. 189,636$7,712,4940.02%
Verition Fund Management LLC 26,921$1,094,8770.02%
Curi RMB Capital, LLC 10,858$441,5950.02%
Tower Research Capital LLC (TRC) 10,359$421,3010.01%
Engineers Gate Manager LP 7,668$311,8580.01%
China Universal Asset Management Co., Ltd. 972$400.01%
PRICE T ROWE ASSOCIATES INC /MD/ 2,076,934$84,4700.01%
MetLife Investment Management, LLC 37,180$1,512,1110.01%
External links

This page lists PTC THERAPEUTICS INC's shareholders in Q2 2023. To view PTC THERAPEUTICS INC's shareholder history, click here.